Comparison of the bronchodilator and cardiac effects of hydroxyphenylorciprenaline and orciprenaline.
D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001980:Bronchi / Q000187:drug effects*; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010636:Phenols / Q000009:adverse effects / Q000494:pharmacology; D012123:Pulmonary Ventilation / Q000187:drug effects; D012119:Respiration / Q000187:drug effects*; D012138:Respiratory Therapy; D013610:Tachycardia / Q000139:chemically induced; D014797:Vital Capacity / Q000187:drug effects
D001993:Bronchodilator Agents; D010636:Phenols; D009921:Metaproterenol